This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Scopus Google Scholar Articles by Rovina, N. Articles by Gratziou, C. PubMed PubMed Citation Articles by Rovina, N. Articles by Gratziou, C. Social Bookmarking                         What's this?

Effectiveness of pharmacotherapy and behavioral interventions for smoking cessation in actual clinical practice

Smoking Cessation Clinic, Pulmonary and Critical Care Department, Evgenidion Hospital, Athens, Greece, nikrovina{at}med.uoa.gr

Ioanna Nikoloutsou

Smoking Cessation Clinic, Pulmonary and Critical Care Department, Evgenidion Hospital, Athens, Greece

Georgia Katsani

Smoking Cessation Clinic, Pulmonary and Critical Care Department, Evgenidion Hospital, Athens, Greece

Efrossini Dima

Smoking Cessation Clinic, Pulmonary and Critical Care Department, Evgenidion Hospital, Athens, Greece

Konstantinos Fransis

Smoking Cessation Clinic, Pulmonary and Critical Care Department, Evgenidion Hospital, Athens, Greece

Charis Roussos

Department of Critical Care and Pulmonary Services, 'Evangelismos' Hospital, University of Athens, Greece

Christina Gratziou

Smoking Cessation Clinic, Pulmonary and Critical Care Department, Evgenidion Hospital, Athens, Greece

Objectives: This study evaluated the effectiveness of behavioral interventions (brief counseling, nonspecific psychological support in groups — NSGS and cognitive behavioral group therapy — CBGT) in combination with bupropion SR for smoking cessation in the field, through a smoking cessation clinic.

Methods: Two-hundred-and-five smokers were enrolled in a 19-week course during 2007/ 2008, and were randomly assigned to: bupropion SR combined with brief counseling (group A), bupropion SR combined with NSGS (group B), bupropion SR combined with CBGT (group C), or CBGT as the only approach (group D).

Results: Continuous abstinence rates at the end of therapy were 53.2% for group A, 62.9% for group B, 50.0% for group C, and 22.2% (p < 0.05) for group D. Sustained abstinence rates in 12 months were 29.6%, 28.1%, 34.3% and 19.4% (p > 0.05), respectively.

Conclusions: Bupropion SR is an effective aid for smoking cessation in clinical practice. NSGT increased the chances for success at the end of therapy when combined with bupropion SR, while CBGT as monotherapy was less effective compared with the approaches including pharmacotherapy. It is suggested that smoking cessation interventions in real-life healthcare settings should be implemented through comprehensive programs using pharmacotherapy where applicable, combined with NSGT, and integrated by specialized healthcare professionals.

Key Words: bupropion SR • behavioral therapy • clinical setting • smoking cessation

Therapeutic Advances in Respiratory Disease, Vol. 3, No. 6, 279-287 (2009)
DOI: 10.1177/1753465809350653


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?